A Histological Analysis and Detection of Complement Regulatory Protein CD55 in SARS-CoV-2 Infected Lungs

Area of Science:

• Pulmonary Medicine
• Immunology
• Pathology

Background:

• Complement system dysregulation in lung alveolar tissue contributes to COVID-19 severity and acute respiratory distress syndrome (ARDS).
• CD55, a transmembrane glycoprotein, regulates complement activation by inhibiting C3 convertase activity.

Purpose of the Study:

• To compare CD55 protein expression in lung specimens from patients with and without COVID-19 and ARDS.
• To investigate the relationship between CD55 expression and lung tissue integrity in COVID-19 and ARDS.

Main Methods:

• Histochemical staining and immunolabeling were employed to analyze CD55 protein expression.
• Lung tissue specimens were categorized into COVID-/ARDS-, COVID-/ARDS+, and COVID+/ARDS+ groups.

Main Results:

• COVID-/ARDS- lung tissues exhibited higher glycosaminoglycan expression and more organized alveolar wall fibers compared to ARDS-affected lungs.
• CD55 expression was significantly stronger and more homogenous in healthy lung tissues (COVID-/ARDS-) than in disrupted COVID-/ARDS+ lung tissues.

Conclusions:

• While alveolar collapse and cellular accumulation characterize COVID+/ARDS+ lungs, CD55 expression warrants further investigation for its role in disease pathogenesis.
• Upregulating CD55 presents a potential therapeutic strategy for managing post-infectious complications of COVID-19 and other inflammatory lung conditions.